Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough

MeSH terms

• Clinical Trials, Phase III as Topic / statistics & numerical data*
• Data Collection*
• Data Interpretation, Statistical*
• Female
• Humans
• Idiopathic Pulmonary Fibrosis / diagnosis
• Idiopathic Pulmonary Fibrosis / drug therapy*
• Idiopathic Pulmonary Fibrosis / mortality
• Indoles / administration & dosage
• Indoles / adverse effects
• Male
• Pyridones / administration & dosage
• Pyridones / adverse effects
• Randomized Controlled Trials as Topic / statistics & numerical data*
• Respiratory Function Tests
• Risk Assessment
• Sensitivity and Specificity
• Severity of Illness Index
• Survival Rate
• Treatment Outcome
• Vital Capacity / drug effects